NAD(P)H:quinone oxidoreductase expression in Cyp1a-knockout and CYP1A-humanized mouse lines and its effect on bioactivation of the carcinogen aristolochic acid I.

[1]  M. Huang,et al.  Endoplasmic reticulum stress mediates aristolochic acid I-induced apoptosis in human renal proximal tubular epithelial cells. , 2012, Toxicology in vitro : an international journal published in association with BIBRA.

[2]  K. Straif,et al.  Upper urinary tract urothelial cancers: where it is A:T , 2012, Nature Reviews Cancer.

[3]  C. Iden,et al.  Biomonitoring of aristolactam-DNA adducts in human tissues using ultra-performance liquid chromatography/ion-trap mass spectrometry. , 2012, Chemical research in toxicology.

[4]  Arthur P. Grollman,et al.  Aristolochic acid-associated urothelial cancer in Taiwan , 2012, Proceedings of the National Academy of Sciences.

[5]  B. Jelaković,et al.  Aristolactam-DNA adducts are a biomarker of environmental exposure to aristolochic acid. , 2012, Kidney international.

[6]  David H Phillips,et al.  Bioactivation versus detoxication of the urothelial carcinogen aristolochic acid I by human cytochrome P450 1A1 and 1A2. , 2012, Toxicological sciences : an official journal of the Society of Toxicology.

[7]  V. Arlt,et al.  Role of P450 1A1 and P450 1A2 in bioactivation versus detoxication of the renal carcinogen aristolochic acid I: studies in Cyp1a1-/-, Cyp1a2-/-, and Cyp1a1/1a2-/- mice. , 2011, Chemical research in toxicology.

[8]  B. Jelaković,et al.  TP53 Mutational signature for aristolochic acid: an environmental carcinogen , 2011, International Journal of Cancer.

[9]  Yuanfeng Wu,et al.  Inhibition of renal NQO1 activity by dicoumarol suppresses nitroreduction of aristolochic acid I and attenuates its nephrotoxicity. , 2011, Toxicological sciences : an official journal of the Society of Toxicology.

[10]  V. Arlt,et al.  The human carcinogen aristolochic acid i is activated to form DNA adducts by human NAD(P)H:quinone oxidoreductase without the contribution of acetyltransferases or sulfotransferases , 2011, Environmental and molecular mutagenesis.

[11]  Ting-Shuan Wu,et al.  Aristolochic acid I induced oxidative DNA damage associated with glutathione depletion and ERK1/2 activation in human cells. , 2011, Toxicology in vitro : an international journal published in association with BIBRA.

[12]  V. Arlt,et al.  Role of cytochromes P450 1A1/2 in detoxication and activation of carcinogenic aristolochic acid I: studies with the hepatic NADPH:cytochrome P450 reductase null (HRN) mouse model. , 2011, Toxicological sciences : an official journal of the Society of Toxicology.

[13]  V. Arlt,et al.  Induction of biotransformation enzymes by the carcinogenic air-pollutant 3-nitrobenzanthrone in liver, kidney and lung, after intra-tracheal instillation in rats. , 2011, Mutation research.

[14]  V. Arlt,et al.  Comparison of activation of aristolochic acid I and II with NADPH:quinone oxidoreductase, sulphotransferases and N-acetyltranferases. , 2011, Neuro endocrinology letters.

[15]  Graham M Lord,et al.  Gene expression changes induced by the human carcinogen aristolochic acid I in renal and hepatic tissue of mice , 2011, International journal of cancer.

[16]  J. Kucab,et al.  Linking environmental carcinogen exposure to TP53 mutations in human tumours using the human TP53 knock‐in (Hupki) mouse model , 2010, The FEBS journal.

[17]  Amanda Smith,et al.  Cytochrome P450 1A2 Detoxicates Aristolochic Acid in the Mouse , 2010, Drug Metabolism and Disposition.

[18]  A. Grollman,et al.  Detoxification of aristolochic acid I by O‐demethylation: Less nephrotoxicity and genotoxicity of aristolochic acid Ia in rodents , 2009, International journal of cancer.

[19]  K. Straif,et al.  A review of human carcinogens--Part A: pharmaceuticals. , 2009, The Lancet. Oncology.

[20]  V. Arlt,et al.  Chemical and molecular basis of the carcinogenicity of Aristolochia plants. , 2009, Current opinion in drug discovery & development.

[21]  D. Nebert,et al.  Generation of a 'humanized' hCYP1A1_1A2_Cyp1a1/1a2(-/-)_Ahrd mouse line harboring the poor-affinity aryl hydrocarbon receptor. , 2008, Biochemical and biophysical research communications.

[22]  J. Hudeček,et al.  Human cytochromes P450 1A1 and 1A2 participate in detoxication of carcinogenic aristolochic acid. , 2008, Neuro endocrinology letters.

[23]  F. Debellé,et al.  Aristolochic acid nephropathy: a worldwide problem. , 2008, Kidney international.

[24]  X. Qi,et al.  Hepatic cytochrome P450s metabolize aristolochic acid and reduce its kidney toxicity. , 2008, Kidney international.

[25]  E. Frei,et al.  Biotransformation enzymes in development of renal injury and urothelial cancer caused by aristolochic acid. , 2008, Kidney international.

[26]  V. Arlt,et al.  Metabolic activation of benzo[a]pyrene in vitro by hepatic cytochrome P450 contrasts with detoxification in vivo : experiments with Hepatic Cytochrome P450 Reductase Null mice , 2008 .

[27]  V. Arlt,et al.  Metabolic activation of carcinogenic aristolochic acid, a risk factor for Balkan endemic nephropathy. , 2008, Mutation research.

[28]  Graham M Lord,et al.  Aristolochic acid mutagenesis: molecular clues to the aetiology of Balkan endemic nephropathy-associated urothelial cancer. , 2009, Carcinogenesis.

[29]  Graham M Lord,et al.  Aristolochic acid mutagenesis: molecular clues to the aetiology of Balkan endemic nephropathy-associated urothelial cancer , 2007 .

[30]  D. Nebert,et al.  Generation of 'humanized' hCYP1A1_1A2_Cyp1a1/1a2(-/-) mouse line. , 2007, Biochemical and biophysical research communications.

[31]  B. Jelaković,et al.  Aristolochic acid and the etiology of endemic (Balkan) nephropathy , 2007, Proceedings of the National Academy of Sciences.

[32]  P. Souček,et al.  THE ENVIRONMENTAL POLLUTANT AND CARCINOGEN 3-NITROBENZANTHRONE AND ITS HUMAN METABOLITE 3-AMINOBENZANTHRONE ARE POTENT INDUCERS OF RAT HEPATIC CYTOCHROMES P450 1A1 AND -1A2 AND NAD(P)H:QUINONE OXIDOREDUCTASE , 2006, Drug Metabolism and Disposition.

[33]  Marie Stiborová,et al.  Human hepatic and renal microsomes, cytochromes P450 1A1/2, NADPH:Cytochrome P450 reductase and prostaglandin H synthase mediate the formation of aristolochic acid‐DNA adducts found in patients with urothelial cancer , 2005, International journal of cancer.

[34]  P. Nioi,et al.  Contribution of NAD(P)H:quinone oxidoreductase 1 to protection against carcinogenesis, and regulation of its gene by the Nrf2 basic-region leucine zipper and the arylhydrocarbon receptor basic helix-loop-helix transcription factors. , 2004, Mutation research.

[35]  Allan B. Okey,et al.  Role of Aryl Hydrocarbon Receptor-mediated Induction of the CYP1 Enzymes in Environmental Toxicity and Cancer* , 2004, Journal of Biological Chemistry.

[36]  A. Jaiswal,et al.  Nrf2 signaling in coordinated activation of antioxidant gene expression. , 2004, Free radical biology & medicine.

[37]  D. Toncheva,et al.  Identification of NQO1 and GSTs genotype frequencies in Bulgarian patients with Balkan endemic nephropathy. , 2004, Journal of nephrology.

[38]  Graham M Lord,et al.  DNA adducts and p53 mutations in a patient with aristolochic acid-associated nephropathy. , 2004, American journal of kidney diseases : the official journal of the National Kidney Foundation.

[39]  B. Sopko,et al.  Human cytosolic enzymes involved in the metabolic activation of carcinogenic aristolochic acid: evidence for reductive activation by human NAD(P)H:quinone oxidoreductase. , 2003, Carcinogenesis.

[40]  Marie Stiborová,et al.  Sudan I is a potential carcinogen for humans: evidence for its metabolic activation and detoxication by human recombinant cytochrome P450 1A1 and liver microsomes. , 2002, Cancer research.

[41]  V. Arlt,et al.  Is aristolochic acid a risk factor for Balkan endemic nephropathy‐associated urothelial cancer? , 2002, International journal of cancer.

[42]  E. Frei,et al.  Human enzymes involved in the metabolic activation of carcinogenic aristolochic acids: evidence for reductive activation by cytochromes P450 1A1 and 1A2. , 2001, Chemical research in toxicology.

[43]  E. Frei,et al.  Isolation of DT-Diaphorase [NAD(P)H Dehydrogenase (Quinone)] from Rat Liver Cytosol: Identification of New Enzyme Substrates, Carcinogenic Aristolochic Acids , 2001 .

[44]  D. Ross,et al.  NAD(P)H:quinone oxidoreductase 1 (NQO1): chemoprotection, bioactivation, gene regulation and genetic polymorphisms. , 2000, Chemico-biological interactions.

[45]  D. Nebert,et al.  Targeted knockout of Cyp1a1 gene does not alter hepatic constitutive expression of other genes in the mouse [Ah] battery. , 2000, Biochemical and biophysical research communications.

[46]  D. Nebert,et al.  Role of the aromatic hydrocarbon receptor and [Ah] gene battery in the oxidative stress response, cell cycle control, and apoptosis. , 2000, Biochemical pharmacology.

[47]  M. Stiborová,et al.  32P-post-labelling analysis of DNA adducts formed by aristolochic acid in tissues from patients with Chinese herbs nephropathy. , 1997, Carcinogenesis.

[48]  C. van Ypersele de Strihou,et al.  Detection of DNA adducts formed by aristolochic acid in renal tissue from patients with Chinese herbs nephropathy. , 1996, Cancer research.

[49]  D W Nebert,et al.  Cyp1a2(-/-) null mutant mice develop normally but show deficient drug metabolism. , 1996, Proceedings of the National Academy of Sciences of the United States of America.

[50]  Y. Li,et al.  Human antioxidant-response-element-mediated regulation of type 1 NAD(P)H:quinone oxidoreductase gene expression. Effect of sulfhydryl modifying agents. , 1994, European journal of biochemistry.

[51]  M. Jadoul,et al.  Rapidly progressive interstitial renal fibrosis in young women: association with slimming regimen including Chinese herbs , 1993, The Lancet.

[52]  D. Nebert,et al.  Regulation of the mammalian cytochrome P1-450 (CYP1A1) gene. , 1989, The International journal of biochemistry.

[53]  P. Talalay,et al.  Regulatory mechanisms of monofunctional and bifunctional anticarcinogenic enzyme inducers in murine liver. , 1988, Cancer research.

[54]  A. Santamaria,et al.  Role of cytochrome P1-450 in the induction of NAD(P)H:quinone reductase in a murine hepatoma cell line and its mutants. , 1987, Carcinogenesis.

[55]  J. W. Simpson.  Collagenolytic activity of snake venom: The effects of enzyme inhibitors on the collagenolytic and trypsin-like enzymes derived from Crotalus atrox venom , 1972 .

[56]  EINZ,et al.  UROTHELIAL CARCINOMA ASSOCIATED WITH THE USE OF A CHINESE HERB ( ARISTOLOCHIA FANGCHI ) , 2022 .